Plain-English translation of NCT03473912 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →This is a research biobank — a collection of tissue and blood samples — designed to help scientists better understand rheumatic diseases like rheumatoid arthritis, lupus, and scleroderma. Researchers will study proteins, genes, and other markers in your samples at the time of diagnosis and during follow-up visits to discover why these diseases develop, how they progress, and which treatments work best for different people.
Rheumatic diseases are autoimmune conditions that are difficult to predict and treat because doctors don't fully understand what causes them or why patients respond differently to medications. By collecting and studying biological samples from many patients over time, researchers hope to develop personalized medicine approaches that could lead to better, more targeted treatments.
You likely qualify if…
You likely don't qualify if…
If you join, a doctor or nurse will draw your blood at a routine clinic visit, or may collect a small sample of joint fluid or skin tissue. These samples will be processed, labeled, and stored in research freezers for scientists to study. You may be asked to provide samples at different time points — both before and after starting new medications — to help researchers track changes in your disease over time.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Israel
Enrollment target
~500 participants
Started
April 2018
Primary completion
November 2037
Age range
18 Years – 120 Years
Last updated on clinicaltrials.gov in March 2019.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yair Levy, Prof.
Meir Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.